> 📌 Previous Analysis: [Applied Materials Reanalysis After 9 Days: Citi’s $710 Street-High and the Trim Discipline](https://mybestinvesting.co.kr/?p=2006)
When we first added Applied Materials (NASDAQ: AMAT) to our core semiconductor-equipment basket in late May 2026, the stock was trading in the low-$400s and the entire bull case rested on a single phrase: the picks-and-shovels supplier to the AI buildout. Nine days ago, in our most recent reanalysis, we flagged that our $620 base-case target was already within striking distance and that insider selling argued for disciplined trimming. Today the stock trades at $694.64, up 10.82% in a single session and roughly 55% over the past month. Our base case has not just been touched — it has been left behind. The stock now sits between our $620 base case and our $720 bull case, while the blended analyst consensus target sits below the current price.
This is exactly the kind of moment that separates a thesis from a trade. When a position triples and then keeps running, the easy reflex is to extrapolate the move or, conversely, to panic-sell into strength. Neither is analysis. The purpose of this reanalysis is to answer four concrete questions with current data: (1) What actually changed on June 25, 2026, when Applied Materials unveiled six new chipmaking systems and the stock closed up 13.42%? (2) Has the original investment thesis strengthened or merely re-rated? (3) What is the stock worth today on a forward earnings base of $16.59 in EPS and a 41.9x forward multiple? And (4) what should current holders actually do at $694 with the consensus average target sitting near $564–594?
Three things frame everything that follows. First, the catalyst is real and product-specific — Applied Materials launched a portfolio aimed squarely at DRAM and high-bandwidth-memory (HBM) packaging, the two fastest-growing pockets of the equipment market. Second, the valuation has stretched to roughly 41.9x forward earnings, well above the company’s own multi-year average, and the average of all analyst targets now implies downside even as the newest Street-high targets imply a further leg up. Third, our discipline from the prior note — trim into strength, hold a long-term core — has been vindicated, and the question now is how much more to trim. This article walks through the company, the industry, the moat, the financials, an updated valuation, the risks, and then four reanalysis-specific sections covering what has changed, where we stand versus our original targets, our revised price targets, and an updated exit plan.
1. Company Overview
Applied Materials is one of the largest semiconductor and display equipment companies in the world, and it sells the machines that physically build chips rather than the chips themselves. That distinction is the entire reason the stock belongs in a portfolio: regardless of which chip designer wins the AI race, the winners must buy deposition, etch, ion implantation, chemical-mechanical planarization (CMP), epitaxy, and process-control tools — and Applied Materials supplies all of those categories under one roof. This breadth across process steps is the company’s structural advantage; it is one of the few suppliers able to sell a customer dozens of distinct tool types and tie them together with integrated materials-engineering know-how.
The business is organized into three reporting segments. Semiconductor Systems is the engine, generating the large majority of revenue by selling wafer-fabrication equipment to logic and memory manufacturers. Applied Global Services (AGS) sells spare parts, equipment upgrades, and service contracts on the company’s enormous installed base; this is the recurring, higher-margin annuity stream that cushions the cyclicality of new-tool sales. Display and Adjacent Markets rounds out the portfolio with equipment for flat-panel displays and related substrates. On a trailing-twelve-month basis the company generated $29.02 billion in sales and $8.51 billion in net income, for a net margin of 29.31% — extraordinary profitability for a capital-equipment business and a direct reflection of pricing power.
Segment Role Characteristics Semiconductor Systems Core revenue driver Sells WFE for logic, foundry, DRAM, NAND; most cyclical Applied Global Services (AGS) Recurring annuity Parts, service, upgrades on installed base; higher-margin, stabilizing Display & Adjacent Markets Diversification Display and substrate equipment; smaller, lumpier
The customer list reads like a roll call of the chip industry: the leading logic foundries, the major DRAM and NAND memory makers, and the integrated device manufacturers. Concentration is real — a handful of customers account for a large share of Semiconductor Systems revenue — but it is concentration in exactly the companies pouring capital into AI capacity. On governance, Applied Materials is overwhelmingly institutionally owned, with the float held across the major index and active funds; insider ownership is modest, which makes the recent pattern of insider selling (discussed in the risk section) a signal worth monitoring rather than a controlling-shareholder concern. With a market capitalization of $551.52 billion and roughly 794 million shares outstanding, the company has graduated firmly into mega-cap territory — a status it did not hold a year ago, when the share price sat near the low end of its 52-week range of $154.46.
2. Industry Analysis
2-1. Market Size & Growth Trajectory
The wafer-fabrication equipment (WFE) market is the foundation on which the entire AI hardware stack is built, and it is in the acceleration phase of a structural up-cycle rather than the mature phase of a normal one. Management’s own framing tells the story: on the back of the June product event, Applied Materials raised its outlook for its calendar-2026 semiconductor-equipment business growth to above 30%. That is not a maintenance-cycle number — it is a number consistent with a once-in-a-generation capacity expansion. The demand pull comes from three reinforcing sources: leading-edge logic for AI accelerators, the explosive ramp of high-bandwidth memory (HBM) needed to feed those accelerators, and advanced packaging that stitches logic and memory together into a single high-performance module.
Crucially, the industry is no longer driven by unit growth in smartphones or PCs, the swing factors that made the old equipment cycle so volatile. It is driven by AI infrastructure capex, where the buyers are the most cash-rich companies on earth and the spending is strategic rather than discretionary. That changes the shape of the cycle: instead of sharp peaks and troughs tied to consumer-electronics inventory, the equipment makers are seeing a longer, more visible ramp as fab projects announced over the past two years move into the tool-installation phase. Applied Materials sits at the center of this because its tools are required at multiple steps of every leading-edge process flow.
2-2. Structural Growth Drivers
Driver one: the transition to gate-all-around (GAA) transistors and 2nm-class logic. As the industry migrates from FinFET to gate-all-around architectures, the number of deposition and epitaxy steps per wafer rises materially. Each new transistor architecture increases the equipment intensity of a wafer — more layers, more precise materials engineering, tighter process control. Applied Materials’ strength in epitaxy, deposition, and materials modification means that every node transition tends to expand its served available market faster than wafer volumes alone would imply. This is a multi-year tailwind: the leading foundries are only at the beginning of their GAA ramps, and the equipment orders for those ramps are still building.
Driver two: high-bandwidth memory and the DRAM super-cycle. AI accelerators are memory-bandwidth-bound, and HBM — vertically stacked DRAM dies connected through advanced packaging — has become the single most supply-constrained component in the AI stack. Building HBM requires far more process steps than conventional DRAM: thinner dies, more precise stacking, and new deposition and planarization techniques. This is the explicit target of the June 25 product launch. The new Producer Avila 2 PECVD system, for example, deposits stress-balanced dielectric films to stabilize the ultra-thin DRAM dies used in high-layer-count HBM, while the enhanced Centura Prime Epi epitaxy system targets next-generation DRAM transistors with a 20% smaller footprint. The HBM ramp is a direct, quantifiable expansion of Applied Materials’ addressable market, and it is only now reaching scale.
Driver three: advanced packaging as a new growth vector. For decades, value in semiconductors was created almost entirely at the transistor level. That is changing. As traditional scaling slows, more performance is being extracted from how chips are connected — chiplets, 3D stacking, and heterogeneous integration. Packaging is becoming a process-intensive, equipment-hungry step in its own right. Three of the six newly launched systems target this opportunity directly: the Opta Quad CMP platform for planarization in advanced packaging, the Nokota VMax 2 electrochemical-deposition system with adaptive pattern tuning for copper plating in 3D stacking, and two eBeam-based metrology and inspection systems (VeritySEM 7AP and SEMVision G7AP) for packaging defect control. Advanced packaging is one of the fastest-growing slices of the equipment market and one where Applied Materials is positioning to take a disproportionate share.
2-3. Competitive Landscape
The semiconductor-equipment industry is an oligopoly in which each major player dominates particular process steps rather than competing head-to-head across the board. ASML leads lithography. Lam Research is a leader in etch and deposition for memory. Tokyo Electron is broad across deposition, etch, and coat/develop. KLA leads process control and inspection. Applied Materials’ position is among the broadest of all — it competes in deposition, epitaxy, ion implantation, CMP, and increasingly in packaging and inspection — which means it benefits from node transitions and packaging growth across a wide set of process steps.
Company Primary strength Positioning Applied Materials Broadest process coverage (depo, epi, implant, CMP, packaging) Most diversified across process steps ASML Lithography (EUV) Single-step monopoly, highest barrier Lam Research Etch & deposition (memory-heavy) Concentrated in memory process steps Tokyo Electron Broad depo/etch/coat Broad but smaller US-listed footprint KLA Process control / inspection Leader in inspection niche
Applied Materials’ advantage in this group is its leverage to the two highest-growth vectors simultaneously — DRAM/HBM and advanced packaging — combined with a very large installed base, which feeds the recurring AGS service stream. Where ASML’s growth is tied to the cadence of EUV adoption and Lam’s to the memory cycle, Applied Materials captures a piece of nearly every wafer at multiple steps, giving it a smoother and broader exposure to the AI-driven equipment up-cycle.
3. Economic Moat Analysis
Moat Type 1: Switching Costs and Process Integration
The deepest part of Applied Materials’ moat is the switching cost embedded in semiconductor manufacturing. Chip fabs are among the most complex factories ever built, and every tool in a process flow is qualified through a long, expensive, risk-laden process. Once a manufacturer has qualified an Applied Materials deposition or epitaxy tool into a production recipe, swapping it for a competitor’s tool means re-qualifying the entire process step — a multi-quarter effort with real yield risk. The result is enormous customer stickiness: incumbency at one node tends to carry into the next, because customers prefer to scale a known, qualified toolset rather than introduce variables into a billion-dollar fab. The evidence shows up in the financials as durable pricing power — a 30.13% operating margin and 29.31% net margin in a capital-equipment business are only possible when customers cannot easily walk away.
Moat Type 2: Scale, Installed Base, and the Services Annuity
The second pillar is scale, expressed two ways. First, R&D scale: developing a new generation of epitaxy or CMP tools requires sustained, heavy investment that only a handful of companies can fund. The June launch of six new systems across DRAM, HBM, packaging, and inspection is itself a demonstration of R&D firepower — few competitors could field that breadth simultaneously. Second, the installed base. Every tool Applied Materials ships becomes a long-lived source of high-margin parts, upgrades, and service revenue through Applied Global Services. This installed-base annuity grows mechanically with every shipment and is far less cyclical than new-tool sales, giving the company a stabilizing floor under earnings during downturns. The combination — re-qualification switching costs plus an ever-growing service annuity — is what allows the company to earn a 39.69% return on equity while carrying a conservative 0.30 debt-to-equity ratio.
Moat Durability Assessment
Will this moat hold for the next five to ten years? The base case is yes, but with two genuine pressure points. The durable side: switching costs and process integration get stronger, not weaker, as nodes grow more complex — GAA, HBM stacking, and advanced packaging all add process steps and tighten qualification requirements, which deepens incumbency. The recurring service base similarly compounds with every shipment. The pressure points are (1) the China question — a meaningful slice of recent revenue has come from Chinese customers, and tightening export controls could erode both sales and, over time, foster domestic competitors — and (2) the risk that advanced-packaging competitors (specialists in bonding, dicing, and inspection) contest the new growth vector before Applied Materials cements share. On balance the moat is intact and arguably widening at the leading edge, but it is not immune; the China exposure in particular is a structural overhang rather than a passing concern.
4. Financial Analysis
Applied Materials’ current financial profile is among the strongest in its history and the fundamental justification for the stock’s re-rating — even if it does not, by itself, justify the multiple. On a trailing-twelve-month basis the company generated $29.02 billion in revenue and $8.51 billion in net income. Gross margin stands at 48.96%, operating margin at 30.13%, and net margin at 29.31% — a margin structure that has expanded as the mix has shifted toward leading-edge tools and high-value services. Return on equity of 39.69% and return on assets of 23.02% confirm that this is a capital-efficient compounder, not a low-return cyclical.
Metric (TTM) Value Commentary Revenue (Sales) $29.02B Driven by leading-edge logic, DRAM/HBM, packaging Net Income $8.51B 29.31% net margin Gross Margin 48.96% Reflects mix shift to high-value tools Operating Margin 30.13% Among the best in capital equipment ROE / ROA 39.69% / 23.02% Strong capital efficiency Debt / Equity 0.30 Conservative balance sheet EPS (ttm) $10.64 — EPS (next FY, consensus) $16.59 Implies ~56% forward EPS growth
The growth picture is accelerating rather than decelerating. The most recent quarter showed sequential sales growth of 11.41% quarter-over-quarter and EPS growth of 33.44% quarter-over-quarter, while full-year EPS is tracking roughly 29.93% higher. Most striking is the gap between trailing and forward earnings: trailing EPS of $10.64 versus a consensus next-fiscal-year EPS of $16.59 implies the Street expects earnings to grow more than 50% as the AI-equipment cycle scales. That forward number is the single most important figure in the valuation, because it is what management’s raised CY2026 guidance (>30% equipment-business growth) and the HBM/packaging product cycle are meant to deliver.
The balance sheet provides ballast. With a debt-to-equity ratio of just 0.30, Applied Materials carries minimal financial risk and generates substantial free cash flow, which it returns to shareholders through buybacks and a dividend that management raised by 15% alongside the June product event — a tangible signal of confidence in the durability of the cash-flow ramp. The combination of accelerating top-line growth, expanding margins, a fortress balance sheet, and a rising shareholder return makes the underlying business genuinely excellent. The debate, then, is not about business quality. It is entirely about price.
5. Valuation
Here is where discipline matters most. At $694.64, Applied Materials trades at a trailing P/E of 65.27 (price ÷ trailing EPS of $10.64) and a forward P/E of 41.87 (price ÷ consensus next-FY EPS of $16.59). Both figures self-check against the live data, and both are well above the company’s own multi-year average, which has historically sat in the low-to-mid 20s for a cyclical equipment maker. The market is pricing Applied Materials not as a cyclical, but as a structural AI-infrastructure compounder. That re-rating may prove justified — but it leaves little margin for error.
Forward P/E method (primary). Anchoring on consensus next-FY EPS of $16.59, the question is what multiple to apply. Our prior base case used a CY2027 EPS estimate of roughly $17.50 at a ~35x multiple. Given the raised CY2026 equipment guidance and the HBM/packaging product cycle, we modestly lift our forward earnings base and consider a range of multiples:
– At 38x forward earnings (a premium to history but below the current 41.9x), fair value on $16.59 EPS is roughly $630 — slightly below today’s price.
– At 42x, in line with where the stock trades today, fair value is roughly $700 — essentially the current price, implying the stock is fully valued.
– At 47x, the kind of multiple embedded in the most bullish Street-high targets, fair value approaches $780–790.
Scenario analysis.
Scenario EPS base (CY2027E) Multiple Implied price vs. $694.64 Bull ~$19.50 ~40.5x $790 +13.7% Base ~$18.50 ~37.8x $700 +0.8% Bear ~$18.50 ~26x $480 −30.9%
Reconciliation with analyst consensus. This is the crux of the current setup. The blended analyst consensus average target sits near $564–$594 — below the current price — which on its face implies downside. But that average is dragged down by stale targets set before the June 25 event; the newest post-event targets cluster far higher: KeyBanc at $750 (raised June 29 from $550), B. Riley at $790, Jefferies at $770, Wells Fargo at $740, BofA at $720, and Citi at $710. In other words, the analysts who have updated since the catalyst see meaningful upside, while the un-updated average still reflects a pre-catalyst world. We side with the updated cohort on direction but treat the dispersion itself as a warning: when fresh targets range from $590 to $790, the market has not settled on what this business is worth, and that uncertainty is precisely what a stretched multiple cannot absorb. Our base case of $700 says the stock is fairly valued today, our bull case of $790 matches the Street high, and our bear case of $480 reflects what a mean-reversion toward ~26x would do if cycle-peak fears take hold. The asymmetry has shifted: roughly +14% to the bull case versus −31% to the bear case is a far less attractive risk/reward than when we first bought in the $400s.
6. Risk Factors
Risk 1: Valuation and cycle-peak re-rating. This is now the dominant risk. At 41.9x forward and 65x trailing earnings, Applied Materials is priced for sustained, multi-year AI-equipment growth with essentially no air pocket. If the equipment cycle shows any sign of plateauing — a single soft guidance print, a pause in fab buildout announcements, or a memory-pricing wobble — the multiple is vulnerable to a sharp de-rating. A reversion from ~42x toward the company’s historical low-to-mid-20s multiple, even on a higher earnings base, would imply roughly 30% downside. After a 55% one-month and 173% year-to-date run, the stock is also exposed to simple momentum unwind: fast money that pushed the price to a record can exit just as quickly. The business does not need to deteriorate for the stock to fall meaningfully; the multiple alone is the fragility.
Risk 2: China exposure and export controls. A meaningful share of recent revenue has come from Chinese customers, and the regulatory environment around semiconductor-equipment exports to China remains fluid and tightening. Further restrictions could directly cut a portion of sales and, more insidiously, accelerate the development of domestic Chinese equipment competitors over the medium term. This is a structural overhang that does not resolve cleanly: even if near-term demand from leading-edge AI customers offsets China softness, the long-term risk of a bifurcated equipment market — with Chinese fabs sourcing domestically — caps the addressable market and is impossible to fully hedge. Any escalation in export policy is a genuine, hard-to-quantify threat to both revenue and the durability of the moat in that region.
Risk 3: Customer concentration and AI capex dependence. Applied Materials’ fortunes are now tightly coupled to AI infrastructure capex, which is itself concentrated among a small number of hyperscalers and leading foundries. The same concentration that powers the current up-cycle is a vulnerability: if hyperscaler capex growth decelerates from its current torrid pace to single digits — whether because of digestion of existing capacity, a shift in AI economics, or a broader macro slowdown — the forward earnings estimates that justify a 42x multiple would come under immediate pressure. Memory in particular is historically the most volatile end-market, and the HBM ramp, while structural, is not immune to the boom-bust dynamics that have always characterized DRAM. A concentrated customer base buying into a single secular theme amplifies both the upside already realized and the downside if that theme cools.
7. Conclusion & Exit Plan
Investment rating: Hold (with active trimming). Applied Materials is an excellent business that has done everything we hoped and more — the original thesis on the AI-equipment buildout has played out faster and more powerfully than our base case assumed. But a great business at 42x forward earnings, after a triple, with the blended consensus target sitting below the price, is a different proposition than the same business at 20x in the $400s. We are not sellers of the long-term core, but we are firm trimmers into this strength. The risk/reward of roughly +14% to our bull case versus −31% to our bear case no longer supports adding, and the prudent posture is to harvest gains while retaining a strategic position in the structural winner.
Entry / add range: We would not initiate new money at $694. A pullback into the $520–$580 range — closer to the blended consensus and a more defensible multiple — would re-open the risk/reward for adds. New buyers chasing the record high are accepting cycle-peak risk with little margin of safety.
Exit conditions:
– Target achieved (trim): Execute the next ~25% trim of the position at the current level around the $700 base case, given it has been reached. Trim an additional ~25% if the $790 bull case is reached.
– Core retention: Retain roughly 50% of the position as a long-term core tied to the GAA, HBM, and advanced-packaging product cycles — the secular drivers are intact even if the near-term multiple is rich.
– Fundamental break (sell): Reduce aggressively if gross margin falls below ~46% for two consecutive quarters, if CY2027 capex from the leading foundries is cut by 20% or more, if the WFE growth guidance is revised below 20%, or if the insider-selling cluster continues alongside a forward multiple persistently above 40x.
– Time-based: Reassess at the next earnings print (Q3 FY2026, expected mid-August 2026) against the prior guidance of roughly $8.95B revenue and $3.36 non-GAAP EPS, and formally re-rate the thesis within six months.
Item Detail Company Applied Materials, Inc. (AMAT) Current Price $694.64 Target Price (Base) $700 Upside (Base) +0.8% Bull / Bear $790 / $480 Rating Hold (active trim) Key Thesis Broad WFE leader leveraged to DRAM/HBM and advanced packaging AI cycle Main Risk 42x forward multiple leaves no margin for a cycle-peak re-rating
—
8. What Changed Since Last Analysis
When we first covered Applied Materials in late May 2026 and through our two subsequent reanalyses in June, the core argument rested on five ideas. Here is an honest accounting of how each has held up.
Idea 1 — “Applied Materials is the broadest picks-and-shovels supplier to the AI buildout.” Strengthened. The June 25 product launch is the clearest validation yet: rather than defending existing share, the company expanded its served market with six new systems spanning DRAM epitaxy, HBM dielectric deposition, advanced-packaging CMP and copper plating, and packaging inspection. This is the thesis made tangible — the company is not a passive beneficiary of the AI cycle but is actively widening the set of process steps it sells into.
Idea 2 — “The CY2026 WFE up-cycle has multi-year visibility.” Strengthened and quantified. At the time we argued the equipment cycle had unusual visibility. Management has now explicitly raised its calendar-2026 semiconductor-equipment business growth outlook to above 30% — a concrete number that converts our qualitative argument into guidance. The cycle is not just visible; it is being upgraded in real time.
Idea 3 — “HBM and advanced packaging are the new growth vectors.” Playing out faster than expected. When we first wrote, advanced packaging and HBM were framed as emerging opportunities. The product launch makes clear they have moved to the center of the company’s strategy and revenue narrative, and management paired the launch with a 15% dividend increase — a signal that the cash-flow durability behind these vectors is real, not aspirational.
Idea 4 — “Switching costs and the service annuity protect margins through the cycle.” Still valid. Margins have held at elite levels — 48.96% gross, 30.13% operating, 29.31% net — confirming the pricing power thesis. Nothing in the recent data challenges this; if anything, the mix shift toward leading-edge tools has reinforced it.
Idea 5 — “Valuation discipline is required; insiders are selling.” More relevant than ever. This was our cautionary idea, and it has become the central one. In the prior note we flagged a CEO-led insider-selling cluster and a forward multiple in the high 30s as reasons to trim. The stock has since run another ~12% and the forward multiple has expanded to ~42x. The discipline we counseled has been vindicated: trimming into the prior strength was correct, and the case for continued trimming is now stronger, not weaker.
New idea since last coverage: A genuinely new angle has emerged from the product launch — the shift of value toward packaging and metrology. The inclusion of two eBeam metrology/inspection systems (VeritySEM 7AP, SEMVision G7AP) in the launch signals Applied Materials is contesting process-control share, a category historically dominated by a specialist competitor. If this gains traction, it is incremental TAM not in our original model. New risk: the speed of the re-rating itself. A stock that has tripled and now trades above the blended analyst target is exposed to momentum unwind in a way it was not when we initiated — a risk that did not exist in the original thesis because the valuation gap did not exist.
9. Current Assessment
Measured against our original analysis point, the position has performed exceptionally. When we initiated coverage in late May 2026, Applied Materials traded in the low-$400s; through our June 12 and June 21 reanalyses the stock moved into the low-$600s, and today it trades at $694.64. From the original coverage price the return is well over 60% in roughly five weeks, and the stock has now blown through the $620 base-case target we set in the prior note. Of our three scenario targets — base $620, bull $720, bear $440 — the base case has been reached and exceeded, and the price now sits about 4% below the prior bull case of $720. In other words, in the span of a few weeks the market has traveled almost the entire distance to our most optimistic prior scenario.
It has been roughly five weeks since initial coverage and about nine days since the last reanalysis, an unusually compressed timeframe driven by the June 25 catalyst and the subsequent wave of analyst upgrades (KeyBanc to $750 on June 29 being the most recent). The 52-week range — $154.46 to $669.22 — underscores how far and fast this has run; the current price has even pushed past the prior 52-week high as the latest leg extended.
In plain terms, our current holding stance is maintaining a reduced core position while continuing to trim. We are not exiting — the secular drivers behind the business are intact and arguably strengthening — but we are actively harvesting gains. The thesis has succeeded so thoroughly that the primary task has shifted from owning the idea to managing the position: locking in a triple while keeping skin in the game for the long-term packaging and HBM cycle. This is a high-quality problem, but it is a position-management problem, not a conviction problem.
10. Revised Price Target & Valuation
We are recalculating fair value with updated inputs and comparing against our prior targets. The two key changes since the last note are (1) management’s raised CY2026 equipment-growth guidance (above 30%), which lifts our CY2027 EPS estimates modestly, and (2) the dramatic multiple expansion to ~42x forward, which forces us to confront how much premium the market is now willing to pay.
Anchoring on a CY2027 EPS estimate of roughly $18.50 in the base case (up from our prior ~$17.50, reflecting the upgraded guidance) and applying a ~37.8x multiple yields a base-case fair value of approximately $700. The bull case lifts CY2027 EPS to ~$19.50 and applies ~40.5x for $790, matching the current Street-high. The bear case holds EPS near $18.50 but applies a ~26x mean-reversion multiple for $480.
Scenario Previous Target Revised Target Change Key Driver Base Case $620 $700 +12.9% Raised CY2026 WFE guidance (>30%); higher CY2027E EPS (~$18.50) Bull Case $720 $790 +9.7% Street-high re-rating; HBM/packaging product cycle; ~40.5x multiple Bear Case $440 $480 +9.1% Higher earnings base, but ~26x mean-reversion if cycle peaks
The changes are driven almost entirely by two forces working in the same direction: a higher earnings base (from raised guidance and the HBM/packaging cycle) and a willingness to apply a higher multiple given the proven momentum and the wall of fresh analyst upgrades. We have raised all three scenario targets, but we have done so cautiously — our base case of $700 sits essentially at the current price, which is our way of saying the stock is now fairly valued, not cheap. Compared with current analyst consensus, we land between the stale blended average (~$564–594, which we view as outdated) and the newest Street-high targets ($740–790, which we view as achievable only in the bull scenario). We agree with the upgraded direction of analyst sentiment but disagree with treating the Street-high as a base case: a $790 print requires both sustained >30% equipment growth and the market holding a ~40x multiple, a combination that leaves no room for disappointment.
11. Updated Exit Plan
Recommended stance: continue holding a reduced core, trim into strength. For current holders, the actionable guidance is to treat the achievement of our base case as the trigger for the next round of profit-taking while preserving a long-term position.
– Trim schedule: Take approximately 25% off the table at the current level near the $700 base case, which has now been reached. Trim a further 25% if the bull-case $790 is achieved. Retain the remaining ~50% as a long-term core tied to the GAA, HBM, and advanced-packaging product cycles.
– Updated stop-loss / impairment triggers — the thesis is broken if:
– Gross margin falls below ~46% for two consecutive quarters (the margin-durability pillar of the moat would be in question);
– Any one of the leading foundries cuts CY2027 capex by 20% or more, or management revises WFE growth guidance below 20% (the cycle-visibility pillar would break);
– The forward P/E stays above 40x for two consecutive quarters while the insider-selling cluster continues (a valuation/insider divergence that historically precedes cycle tops);
– China revenue falls 30%+ without offsetting leading-edge demand.
– Next review date: Reassess at the Q3 FY2026 earnings print (expected mid-August 2026) against the prior guidance of roughly $8.95B revenue and $3.36 non-GAAP EPS, and conduct a formal re-rating within six months (by end-December 2026) or sooner if a stop-loss trigger fires.
One-sentence summary: For current holders, we recommend banking the triple by trimming a quarter of the position into the $700 base case and another quarter at $790, while retaining a long-term core in what remains one of the broadest equipment beneficiaries of the AI buildout — but we would not commit new capital at 42x forward earnings.
—
This article is for informational purposes only and does not constitute investment advice. All data sourced from public filings, analyst reports, and news as of the publication date. Invest at your own discretion.
This content is general investment information provided to an indefinite/unspecified audience by a quasi-investment advisory business registered under Korea’s Financial Investment Services and Capital Markets Act, and is not personalized 1:1 investment advice tailored to any individual investor. This analysis is for informational purposes only and is not a solicitation to invest. All investment decisions and their consequences rest solely with the investor. The estimates and assumptions in this report are as of the writing date (2026-06-30) and may not materialize depending on market conditions and geopolitical variables. Financial data used reflects sources such as company filings and analyst consensus, and the scenarios and price targets represent the author’s conservative assessment. All investments carry the risk of principal loss, and past performance or analytical track record does not guarantee future results. As of the writing date, the author currently holds a position in this stock; this article is a review of an actual position. The author’s holdings and positions may change without prior notice depending on market conditions.
함께 읽으면 좋은 글
- 버크셔 해서웨이 그렉 아벨 첫 분기 분석: 3,974억 달러 현금과 100억 달러 알파벳 베팅이 여는 포스트 버핏 시대
- UnitedHealth Stock Turnaround 2026: Why an 83.9% Medical Cost Ratio Signals the Recovery Is Real — and the Path Back to $500
- Danaher Bioprocessing Recovery and the Masimo Acquisition: Why DHR’s $9.11 Forward EPS Points to 23% Upside
- AutoZone Megahub and Commercial DIFM Growth: Why the Post-Earnings Selloff Is a 30% Upside Opportunity in 2026
- Airbnb 2026 Summer Release Analysis: How Services, AI, and Boutique Hotels Expand the Moat — and the Path to $188